EUVIMEDEUVIMED entdecken
Crossref

Branched DNA Nanoplatform-Based Multivalent PROTACs for Tumor Microenvironment-Responsive Degradation of Telomere-Binding Proteins in Tumor Therapy

Hanyin Zhu, Xintong Li, Hong Wang, Huarui Liu, Dandan Li, Changping Yang, Baoquan Ding iD, Jianbing Liu iD

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.6c02181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Hanyin Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology, Beijing100190, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, DNA, Telomeric Repeat Binding Protein 1, Neoplasms. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation systems have been widely employed in biomedical applications. Herein, we report a branched DNA nanoplatform-based multivalent proteolysis-targeting chimera (PROTAC) for efficient degradation of telomeric repeat-binding factor proteins (TRF1/2) in vivo. In our design, a branched DNA-based scaffold with predesigned numbers of PROTACs utilizing telomere mimics as warheads can be synthesized to coassemble with pro-melittins for efficient Legumain-responsive intratumoral permeation. After cellular uptake, the protein degradation units can be subsequently released by GSH reduction to recruit their target proteins (TRF1/2) and key E3 ligases. Owing to covalent characteristics and optimized spatial positions, the branched PROTACs can achieve a multivalent cooperative effect to enhance their degradation efficiency and trigger a series of subsequent cellular behaviors for tumor therapy while showing minimal side effects on normal cells. This tailored targeted protein degradation system based on a branched DNA nanoplatform presents a new avenue for development of precise therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentDNATelomeric Repeat Binding Protein 1NeoplasmsProteolysis Targeting ChimeraHumansAnimalsDNA NanostructuresTelomereCell Line, TumorProteolysisMice

Stichwörter der Autor:innen

DNA nanotechnologyPROTACdrug deliveryself-assemblytumor therapy

Substanzen

Proteolysis Targeting ChimeraDNATelomeric Repeat Binding Protein 1

Autor:innen und Institutionen

  • Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology, Beijing100190, China.
  • University of Chinese Academy of Sciences, Beijing100049, China.

ORCID-Profile: Baoquan Ding, Jianbing Liu

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Sciences
  • National Key Research and Development Program of China

Zitieren

APA

Zhu, H., Li, X., Wang, H., Liu, H., Li, D., Yang, C., Ding, B., & Liu, J. (2026). Branched DNA Nanoplatform-Based Multivalent PROTACs for Tumor Microenvironment-Responsive Degradation of Telomere-Binding Proteins in Tumor Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02181

Vancouver

Zhu H, Li X, Wang H, Liu H, Li D, Yang C, et al. Branched DNA Nanoplatform-Based Multivalent PROTACs for Tumor Microenvironment-Responsive Degradation of Telomere-Binding Proteins in Tumor Therapy. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02181

BibTeX
@article{Zhu2026,
  author = {Zhu, Hanyin and Li, Xintong and Wang, Hong and Liu, Huarui and Li, Dandan and Yang, Changping and Ding, Baoquan and Liu, Jianbing},
  title = {Branched DNA Nanoplatform-Based Multivalent PROTACs for Tumor Microenvironment-Responsive Degradation of Telomere-Binding Proteins in Tumor Therapy},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.6c02181}
}
Kostenlos starten →